SCIENCE FOR HUMANITY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SCIENCE FOR HUMANITY
Largest movements
- Current investments -€42,761
down €42,761 (-100%), from €42,761 to €0
- Receivables within one year -€38,815
down €38,815 (-72.0%), from €53,936 to €15,122
of which Trade receivables: -€31,196
- Cash +€35,737
up €35,737 (+50.0%), from €71,420 to €107,157
mainly Net result for the year (+€48,297) and Current investments (+€42,761)
- Other debts -€57,673
down €57,673 (-65.4%), from €88,221 to €30,548
- Reserves +€49,032
up €49,032 (+700%), from €7,000 to €56,032
- Trade debts -€27,472
down €27,472 (-99.9%), from €27,489 to €17
- Tax, wage and social debts -€23,656
down €23,656 (-90.7%), from €26,073 to €2,418
- Advances received +€14,664
new in 2025: €14,664
- Gross operating margin -€33,803
down €33,803 (-32.2%), from €105,071 to €71,268
- Taxes -€3,731
down €3,731 (-14.2%), from €26,336 to €22,605
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €168,118 | €122,279 | -€45,840 | -27.3% |
| Current assets | 29/58 | €168,118 | €122,279 | -€45,840 | -27.3% |
| Amounts receivable within one year | 40/41 | €53,936 | €15,122 | -€38,815 | -72.0% |
| Trade receivables | 40 | €45,860 | €14,664 | -€31,196 | -68.0% |
| Other amounts receivable | 41 | €8,076 | €458 | -€7,619 | -94.3% |
| Current investments | 50/53 | €42,761 | €0 | -€42,761 | -100% |
| Cash at bank and in hand | 54/58 | €71,420 | €107,157 | +€35,737 | +50.0% |
| Deferred charges and accrued income | 490/1 | €0 | - | = | |
| Total equity and liabilities | 10/49 | €168,118 | €122,279 | -€45,840 | -27.3% |
| Equity | 10/15 | €26,335 | €74,632 | +€48,297 | +183% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €7,000 | €56,032 | +€49,032 | +700% |
| Distributable reserves | 133 | €7,000 | €56,032 | +€49,032 | +700% |
| Profit (loss) carried forward | 14 | €735 | €0 | -€735 | -100% |
| Amounts payable | 17/49 | €141,783 | €47,647 | -€94,137 | -66.4% |
| Amounts payable within one year | 42/48 | €141,783 | €47,647 | -€94,137 | -66.4% |
| Trade debts | 44 | €27,489 | €17 | -€27,472 | -99.9% |
| Suppliers | 440/4 | €27,489 | €17 | -€27,472 | -99.9% |
| Advances received on contracts in progress | 46 | - | €14,664 | +€14,664 | |
| Taxes, remuneration and social security | 45 | €26,073 | €2,418 | -€23,656 | -90.7% |
| Taxes | 450/3 | €26,073 | €2,418 | -€23,656 | -90.7% |
| Other amounts payable | 47/48 | €88,221 | €30,548 | -€57,673 | -65.4% |
| Other operating charges | 640/8 | €613 | €828 | +€214 | +35.0% |
| Gross operating margin | 9900 | €105,071 | €71,268 | -€33,803 | -32.2% |
| Operating profit (loss) | 9901 | €104,458 | €70,441 | -€34,017 | -32.6% |
| Financial income | 75/76B | €103 | €625 | +€522 | +504% |
| Recurring financial income | 75 | €103 | €625 | +€522 | +504% |
| Financial charges | 65/66B | €304 | €164 | -€140 | -46.1% |
| Recurring financial charges | 65 | €304 | €164 | -€140 | -46.1% |
| Profit (loss) for the period before taxes | 9903 | €104,257 | €70,902 | -€33,355 | -32.0% |
| Income taxes | 67/77 | €26,336 | €22,605 | -€3,731 | -14.2% |
| Profit (loss) for the period | 9904 | €77,921 | €48,297 | -€29,624 | -38.0% |
| Profit (loss) for the period to be appropriated | 9905 | €77,921 | €48,297 | -€29,624 | -38.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.